A new pathway for primary aldosteronism treatment
Authors:
- 7 February 2025
- journal article
- Published by Elsevier in The Lancet
- Vol. 405 (10479) , 599-601
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Unilateral Primary Aldosteronism: Long-Term Disease Recurrence After AdrenalectomyHypertension, 2024
- Health Care Challenges in the Management of Primary Aldosteronism in Southeast AsiaThe Journal of Clinical Endocrinology & Metabolism, 2024
- Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysisThe Journal of Clinical Endocrinology & Metabolism, 2023
- [11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trialNature Medicine, 2023
- Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort studyThe Lancet Diabetes & Endocrinology, 2022
- Outcomes of a Specialized Clinic on Rates of Investigation and Treatment of Primary AldosteronismJAMA Surgery, 2021
- Radiofrequency ablation for adenoma in patients with primary aldosteronism and hypertension: ADERADHTA, a pilot studyJournal Of Hypertension, 2020
- Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysisThe Lancet Diabetes & Endocrinology, 2018
- Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohortThe Lancet Diabetes & Endocrinology, 2017
- Role of Unilateral Adrenalectomy in Bilateral Primary Aldosteronism: A 22-Year Single Center ExperienceThe Journal of Clinical Endocrinology & Metabolism, 2009